Viewing Study NCT01182168

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:33 PM
Ignite Modification Date: 2026-01-27 @ 2:58 AM
Study NCT ID: NCT01182168
Status: COMPLETED
Last Update Posted: 2016-03-31
First Post: 2010-08-11
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bladder Cancer View
None Renal Pelvis Cancer View
None Ureter Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CISPLATIN View
None GEMCITABINE View
None RAD001 (EVEROLIMUS) View
None 10-106 View